Dr. Foxton on results of drug combination with PSMA agent for prostate cancer
“In terms of the minimal overlapping toxicity, our non-clinical data from the xenograft model showed minimal toxicity with the combination,” says Caroline Foxton, PhD.
“In terms of the minimal overlapping toxicity, our non-clinical data from the xenograft model showed minimal toxicity with the combination,” says Caroline Foxton, PhD.
These skills trainings combine didactic lectures and hands-on sessions instructed by highly accomplished and experienced Faculty. The HOSTs are among the most popular educational offerings…
The OFFICIAL site of the American Urological Association’s 2024 Annual Meeting, May 3 – May 6, 2024 in San Antonio, TX. AUA2024 explores the latest…
What a month of urology excitement April has been! It was wonderful to see over 10,000 urologists join us in Paris at EAU24. All with…
“This clinical study has the potential to demonstrate the value of Chimeric Antigen Receptor (CAR) T cell therapy in solid cancers such as kidney cancer…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
The approval was based on data from three phase 3 trials which compared the efficacy of different dosing regimens of pivmecillinam to placebo, to another…
Researchers conducted a systematic review and meta-analysis to assess the relationship between GLP-1RA treatment and blood pressure effects.
“It’s a system that is still not being used to its maximum capability, which is exciting. That means we can continue evolving,” says Jaschar Shakuri-Rad,…
prostate cancer, Brief Androgen Suppression and Stereotactic Radiation Therapy, High-Risk Prostate Cancer, FASTR trial, FASTR-2 Trials, stereotactic ablative radiotherapy (SABR), SABR in high-risk prostate cancer.
The Institute for Leadership & Business (ILB) Track features seven courses bundled into one convenient package and offered over 4 days. Includes both in-person and…